Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02012738
Other study ID # ERC-2012-AdG 323977 Memo TV
Secondary ID
Status Completed
Phase N/A
First received October 9, 2013
Last updated May 12, 2016
Start date October 2013
Est. completion date March 2016

Study information

Verified date May 2016
Source University of Konstanz
Contact n/a
Is FDA regulated No
Health authority South Africa: Human Research Ethics CommitteeGermany: Ethics Commission
Study type Interventional

Clinical Trial Summary

Escalating violence is omnipresent in South African townships and can be traced back to two core mechanisms: a trauma-related hyper-arousal and a positive rewarding perception of violence. In the past, there was no therapeutic intervention available addressing both, trauma and the so-called appetitive aggression. The University of Konstanz has developed a culturally sensitive and scientifically based short-term intervention for the treatment of traumatized patients, the Narrative Exposure Therapy (NET), that has proven its effectiveness in various randomized clinical studies in different war-affected populations. Recently, the NET has been adapted for the forensic offender rehabilitation (FORNET) by also addressing the perpetration of violence related to a self-rewarding perception of the exposure with violence. It has shown to be effective in reducing the number of committed offenses in a perpetrator sample in Burundi and to reduce PTSD symptoms in a perpetrator sample in the Democratic Republic of the Congo. In this study, we investigated the therapeutic efficiency of FORNET in a randomized clinical control trial with a sample of former offenders of the townships of Cape Town. In addition to the previous studies, we specifically addressed the context of ongoing stress and linked our findings to epigenetic markers of stress and violence. Participants were followed over a period of up to 25-months post-treatment. The FORNET was also disseminated to local staff of our collaboration partners from the South African Universities and an organization working in the townships to warrant sustainability of the therapeutic intervention.


Description:

A group of 290 former young male offenders and young males at risk for perpetrating or becoming victims of crime (age 10-40) from Cape Town, recruited via a community based skill-training program has been interviewed in a first step. Participants with neurological or psychiatric disorders other than those resulting from exposure to traumatic stress, like chronic psychosis, were excluded from participation in the study but received referrals in the professional health care system, if necessary.

We applied standardised clinical questionnaires in a semi-structured interview for the assessment of exposure to traumatic stress (Children Exposed to Community Violence (CEVC)), trauma symptomatology (PSS-I for diagnosis of post-traumatic stress disorder), aggression (Appetitive Aggression Scale (AAS); Buss & Perry Aggression Questionnaire), offense types checklist (from the AAS) and related drug abuse, psychosocial functioning (Work and Social Adjustment Scale, WSAS) and suicidality (M.I.N.I. 6.0.0., shortened version). Additionally, we used a questionnaire about social acknowledgement (Social Acknowledgement Questionnaire) and substance dependence (M.I.N.I. version 6.0.0).

We set up a randomised clinical intervention trial for the treatment of former offenders that covers violence perpetration on the one hand and traumatization on the other. 90 participants were chosen by the highest aggression scale scores and a certain threshold of trauma symptoms. 17 participants received FORNET, while 14 matched participants received CBT and another 7 matched participants treatment as usual (Waiting List camp) in a camp. Matching took place according to the severity of trauma symptomatology, aggressive behavior and suicidality. 36 participants didn't receive intervention and weren't part of the camp (Waiting List no camp) but were included in the follow-ups. In order to compare the treatment effect with the two control groups and follow the long-term effects, post-treatment assessments with the initial survey were performed about 8, 18 and 25 months post-treatment.

After the follow-ups, 17 FORNET participants and 11 CBT participants were included in the analysis. Two CBT clients had been excluded since they had not come to the follow-ups, one CBT client died a relatively sudden death due to a severe disease. The camp waiting list had been reduced to only six persons since one participant of the waiting list has been stabbed to death in a gang fight. Therefore a combined waiting list has been emerged from the two waiting lists ("camp" and "no camp"). 13 men from the "no camp"-waiting list were excluded since they have not been to the follow ups. From the residual 21 clients from this waiting list, 11 have been matched (together with the six participants from the "camp"-waiting list) with the participants from the FORNET and CBT group in terms of post traumatic stress symptom severity, level of appetitive aggression and suicidality. In the end 17 FORNET-, 11CBT- and 17 waiting list-attendees have been included into the analysis, hence a total sample size of 45 participants.

The 2 subjects of the control group, that still fulfilled the criteria for the therapy study and were interested in it, received FORNET by trained ZA staff for ethical reasons and to examine whether it is possible to effectively disseminate FORNET.

In addition to the subjective data, we will corroborate the results with the assessment of epigenetic consequences of appetitive aggression and trauma and investigate its significance and persistence in the long-term course of the study. We propose that specific DNA methylation patterns are important markers of environmentally driven mental health pathologies, such as chronic aggression/violence and traumatic stress in such a sample of perpetrators or young males at risk for perpetration. Further, we will test the stability of DNA methylation and its potential modification over a period of up to 25 months by behavioural intervention (FORNET).

Saliva samples (2ml) were collected through a non-invasive method using Oragene-Discover (OGR- 500) Collection Kit (DNA genotek, Ontario, Canada). We will collect two DNA saliva samples and one RNA saliva sample. Methylation patterns will be assessed at the University of Stellenbosch (Prof. Soraya Seedat), focussing on markers of trauma and violence.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Male
Age group 10 Years to 40 Years
Eligibility Inclusion Criteria:

- High levels of PTSD symptoms (i.e. Scores on the PSS-I > 7 points)

- High levels of appetitive aggression (i.e. Scores on the Appetitive Aggression Scale (AAS) > 8 points)

- participants are recruited through the community based re-integration program

Exclusion Criteria:

- acute psychotic episode

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
FORNET
8 individual sessions: 1 lifeline 6 exposure sessions 1 outlook
CBT
7 individual sessions, according to the "Integrated cognitive behavior change program" manual, Bush et al., 1997, National Institute of Corrections, US Dept. of Justice.
Other:
Waiting List Control Group (camp)
Participants, if still meeting the criteria and interested, will receive FORNET by local counsellors after the 8-months follow up.
Waiting List Control Group (no camp)
Participants, if still meeting the criteria and interested, will receive FORNET by local counsellors after the 8-months follow up.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
University of Konstanz University of Cape Town, University of Stellenbosch

Country where clinical trial is conducted

South Africa, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in PTSD symptom severity with the PSS-I the Post-traumatic Stress Disorder Scale- Interview (PSS-I) post-treatment at 6- and 12-month follow-up 8, 18 and 25- month follow-up No
Primary Change in Attraction to violence with the Appetitive Aggression Scale (AAS) post-treatment at 6- and 12-month follow-up 8, 18 and 25- month follow-up No
Primary Change in Methylation Pattern of the Glucocorticoid Receptor promoter region via saliva samples 8, 18 and 25- month follow-up No
Primary Change in Self-committed violence with the AAS offense list 8, 18 and 25- month follow-up No
Primary Influence of Social Acknowledgement with Social Acknowledgement Questionnaire (SAQ) 8, 18 and 25- month follow-up No
Primary Influence of drug abuse related to violence on number of offenses with the offense checklist (from the AAS) 8, 18 and 25- month follow-up No
Primary Change in Epigenetic Markers (methylation patterns) of violence in the androgen receptor promoter region via saliva samples 8, 18 and 25- month follow-up No
Secondary Change in Strength of suicidal ideation measured with the MINI 6.0.0. 8, 18 and 25- month follow-up No
Secondary Change in Psychosocial Functioning measured with the WSAS (Work and Social Adjustment Scale) 8, 18 and 25- month follow-up No
Secondary Change in Depression severity with the PHQ-9 8, 18 and 25- month follow-up No
See also
  Status Clinical Trial Phase
Terminated NCT05189977 - A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline Phase 1
Completed NCT01806168 - rTMS in the Treatment of PTSD N/A
Not yet recruiting NCT06194851 - Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD Phase 2
Completed NCT02187224 - Progesterone Effect on Individuals Diagnoses With AD and PTSD. Phase 2/Phase 3
Completed NCT02549508 - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD N/A
Not yet recruiting NCT01940549 - Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder N/A
Not yet recruiting NCT06419959 - NightWare and Cardiovascular Health in Veterans With PTSD N/A
Terminated NCT03209882 - Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD) N/A
Completed NCT04891614 - The PRISM Pilot Trial for Post-Traumatic Stress Disorder N/A
Recruiting NCT05407337 - The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme N/A
Completed NCT02030522 - Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma N/A
Completed NCT01729325 - Prevention of Post-Traumatic Stress Disorder in Soldiers Phase 2
Completed NCT02053532 - Functional Brain Imaging in PTSD N/A
Not yet recruiting NCT02598024 - Treating Earthquake in Nepal Trauma (TENT) Trial 2016 N/A
Terminated NCT02237703 - Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD) N/A
Withdrawn NCT02356861 - LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans N/A
Not yet recruiting NCT05974631 - Evaluating Treatments for Suicidal Veterans With PTSD N/A
Not yet recruiting NCT06288594 - TraumaRelief App: A Pilot RCT Assessing Feasibility and Acceptability N/A
Completed NCT01847469 - Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence Phase 2
Completed NCT01691092 - PET Imaging of mGLuR5 With Drug Challenge N/A